SELLAS Life Sciences (SLS) Gross Margin (2012 - 2022)

SELLAS Life Sciences (SLS) reported Gross Margin of 90.0% for Q1 2022, down 825.0% year-over-year from 12.41% in Q1 2021, and down 5.0% quarter-over-quarter from 94.74% in Q2 2021.

SELLAS Life Sciences (SLS) Gross Margin (2012 - 2022) Analysis & Trends

SELLAS Life Sciences (SLS) has 7 years of Gross Margin data on file, last reported at 90.0% in Q1 2022.

  • Gross Margin for Q1 2022 came in at 90.0%, down 825.0% year-over-year; the trailing twelve-month figure through Dec 2022 was 90.0% (down 737.0% YoY), and the FY2022 annual result was 90.0%, down 737.0% from the prior year.
  • Gross Margin eased to 90.0% in Q1 2022 per SLS's latest filing, from 94.74% in the prior quarter.
  • Over five years, Gross Margin peaked at 100.0% in Q4 2020 and troughed at 90.0% in Q1 2022.
  • A 3-year average of 95.75% and a median of 96.49% in 2021 frame the typical range for Gross Margin.
  • On a YoY basis, Gross Margin climbed as much as 825 bps in 2022 and fell as far as 825 bps in 2022.
  • A 3-year view of Gross Margin shows it stood at 100.0% in 2020, then dropped by 5 bps to 94.74% in 2021, then dropped by 5 bps to 90.0% in 2022.
  • Business Quant data shows SLS's Gross Margin at 90.0% in Q1 2022, 94.74% in Q2 2021, and 98.25% in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 SELLAS Life Sciences 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 90.00%
Jun 30, 2021 94.74%
Mar 31, 2021 98.25%
Dec 31, 2020 100.00%
Jun 30, 2015 86.16%
Mar 31, 2015 85.71%
Dec 31, 2014 85.04%
Sep 30, 2014 84.75%
Jun 30, 2014 85.11%
Mar 31, 2014 84.77%
Dec 31, 2013 91.80%
Sep 30, 2013 53.64%
Jun 30, 2013 100.00%
Mar 31, 2013 100.00%
Dec 31, 2012 100.00%